Search research articles
Contact Us
Filters
Showing results (131-140 of 141) with videos related to
Page
of 15
Sort By:
European Urology Oncology
|
August 6, 2024
Clinical Outcomes and Targeted Genomic Analysis of Renal Cell Carcinoma Brain Metastases Treated with Stereotactic Radiosurgery
Jennifer Ma, Luke Del Balzo, Henry Walch, et al.
Cell Reports. Medicine
|
October 31, 2025
Identification of therapeutic targets for renal medullary carcinoma via integrated genomic and transcriptomic profiling
Pavlos Msaouel, Nizar M Tannir, Funda Meric-Bernstam, et al.
Genome Biology
|
November 19, 2016
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures
Yasin Şenbabaoğlu, Ron S Gejman, Andrew G Winer, et al.
Genome Biology
|
March 3, 2017
Erratum to: Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures
Yasin Şenbabaoğlu, Ron S Gejman, Andrew G Winer, et al.
Cancer Cell
|
April 16, 2021
Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy
Chirag Krishna, Renzo G DiNatale, Fengshen Kuo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2017
The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma
Jacob D Soumerai, Andrew D Zelenetz, Craig H Moskowitz, et al.
Cancer Cell
|
April 17, 2018
Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer
Matthew D Hellmann, Tavi Nathanson, Hira Rizvi, et al.
Cancer Discovery
|
June 27, 2022
A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma
Phillip M Rappold, Lynda Vuong, Josef Leibold, et al.
Urologic Oncology
|
August 17, 2025
Developing biomarkers and methods of risk stratification: Consensus statements from the International Kidney Cancer Symposium North America 2024 Think Tank
Daniel D Shapiro, Edwin Jason Abel, Laurence Albiges, et al.
Cancer Cell
|
June 4, 2026
Hypoxia shapes both therapeutic response and resistance in metastatic clear cell renal cell carcinoma
Lynda Vuong, Andrew E Cornish, Jennifer Pfeil, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 141) with videos related to
Sort By:
Page
of 15
European Urology Oncology
|
August 6, 2024
Clinical Outcomes and Targeted Genomic Analysis of Renal Cell Carcinoma Brain Metastases Treated with Stereotactic Radiosurgery
Jennifer Ma, Luke Del Balzo, Henry Walch, et al.
Cell Reports. Medicine
|
October 31, 2025
Identification of therapeutic targets for renal medullary carcinoma via integrated genomic and transcriptomic profiling
Pavlos Msaouel, Nizar M Tannir, Funda Meric-Bernstam, et al.
Genome Biology
|
November 19, 2016
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures
Yasin Şenbabaoğlu, Ron S Gejman, Andrew G Winer, et al.
Genome Biology
|
March 3, 2017
Erratum to: Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures
Yasin Şenbabaoğlu, Ron S Gejman, Andrew G Winer, et al.
Cancer Cell
|
April 16, 2021
Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy
Chirag Krishna, Renzo G DiNatale, Fengshen Kuo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2017
The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma
Jacob D Soumerai, Andrew D Zelenetz, Craig H Moskowitz, et al.
Cancer Cell
|
April 17, 2018
Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer
Matthew D Hellmann, Tavi Nathanson, Hira Rizvi, et al.
Cancer Discovery
|
June 27, 2022
A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma
Phillip M Rappold, Lynda Vuong, Josef Leibold, et al.
Urologic Oncology
|
August 17, 2025
Developing biomarkers and methods of risk stratification: Consensus statements from the International Kidney Cancer Symposium North America 2024 Think Tank
Daniel D Shapiro, Edwin Jason Abel, Laurence Albiges, et al.
Cancer Cell
|
June 4, 2026
Hypoxia shapes both therapeutic response and resistance in metastatic clear cell renal cell carcinoma
Lynda Vuong, Andrew E Cornish, Jennifer Pfeil, et al.
Page
of 15